Legend Biotech Usa Inc
Clinical trials sponsored by Legend Biotech Usa Inc, explained in plain language.
-
Engineered immune cells take aim at tough lung cancer
Disease control OngoingThis early-phase trial tests a new treatment called LB2102, which uses a patient's own immune cells (T-cells) that are modified in a lab to recognize and attack cancer cells that carry a protein called DLL3. The study includes about 41 adults with advanced small cell lung cancer …
Phase: PHASE1 • Sponsor: Legend Biotech USA Inc • Aim: Disease control
Last updated May 26, 2026 08:20 UTC
-
Engineered immune cells take on Hard-to-Treat digestive cancers
Disease control OngoingThis early-phase trial tests a new treatment called LB1908, which uses a patient's own immune cells (T-cells) that have been modified to recognize and attack cancer cells that have a protein called claudin 18.2 on their surface. The study includes adults with advanced stomach, es…
Phase: PHASE1 • Sponsor: Legend Biotech USA Inc • Aim: Disease control
Last updated May 22, 2026 13:50 UTC